All the latest news on the marijuana space delivered directly to your inbox.
Read our Investor Dashboard on OTC:ABCCF TSX.v ABCN
There will be a sudden wave of "Marijuana Millionaires" in 2017 - will you be one?

13x13x1 READ MORE
How To Invest in the Emerging Marijuana Market.
Production Bottleneck Spells Opportunity for Canada’s Cannabis Producers

While developments in U.S. marijuana markets have no trouble attracting headlines, many seasoned investors have discovered a more predictable method of capitalizing on the cannabis boom by turning their attention to the north.

13x13x1 READ MORE
InMed (CSE: IN; OTCQB: IMLFF) Retains Consultant Ben Paterson for Biosynthesis Development

InMed Pharmaceuticals (CSE: IN, OTCQB: IMLFF) announced today that it has retained the consulting services of Ben Paterson, P.E., to assist in defining the pathway for the scale-up, purification, and manufacturing strategies for InMed’s cannabinoid biosynthesis program.

13x13x1 READ MORE
Las Vegas Marijuana Dispensary to Stay Open 24 Hours a Day, Others Likely To Follow

Recreational marijuana in Las Vegas will be available 24 hours a day, seven days a week starting today. Approved by the city council earlier this week, Oasis Cannabis is the first marijuana dispensary in Sin City with no closing time.

13x13x1 READ MORE
Cannabis Wheaton Announces Kanata Earth as First Participant in Wheaton Licensing Program and Cornerstone of Its First Nations Strategy

Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) welcomes Kanata Earth Inc. as the first participant in the recently announced Wheaton Licensing Program and the cornerstone of its First Nations strategy.

13x13x1 READ MORE
Please see full disclaimers on the website applicable to all content provided by TSI, wherever published or re-published:

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed inv­estment advisor. 

32x32x1   32x32x2
9375 E Shea Blvd Ste 100
Scottsdale 85260
©2019, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.